PubMed · 15591662
Linezolid.
Abstract
Linezolid is an oxazolidinone antibacterial agent that acts by inhibiting the initiation of bacterial protein synthesis. Linezolid has a wide spectrum of activity against gram-positive organisms including methicillin resistant staphylococci, penicillin resistant pneumococci and vancomycin resistant enterococcus faecalis and E. faecium. Linezolid has a good bio-availability orally and could be switched from parenteral to oral therapy while treating serious infections. Linezolid is well tolerated in children.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Manish Narang, Sunil Gomber. 2004. Linezolid.. https://pubmed.ncbi.nlm.nih.gov/15591662/
Cite the original work for its findings. Save a collection to share your selection of sources.